Skip to main content
Clinical Trials/NL-OMON56129
NL-OMON56129
Recruiting
Phase 2

Primary percutaneous placement of metal stents for palliative biliary drainage in patients with a primary malignant perihilar stricture - TESLA

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
bile duct cancer
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
112
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Written informed consent must be given according to ICH/GCP, and
  • national/local regulations.
  • Unresectable primary malignant perihilar obstruction on imaging with
  • histopathological confirmation or high clinical suspicion (as determined by the
  • multidisciplinary hepatobiliary team)
  • Symptomatic hyperbilirubinemia (a combination of a total bilirubin level \>20
  • mmol/l, and/or jaundice and/or loss of appetite and/or dark urine and/or
  • steatorrhea)

Exclusion Criteria

  • Fluctuation or spontaneous decrease of a total bilirubin level before start
  • of any treatment suggesting potential benign origin.
  • Patients who underwent previous drainage procedures endoscopically or
  • percutaneously with an internalized biliary catheter
  • Clinical signs of cholangitis. Cholangitis was defined as both fever (i.e.
  • body temperature \>38\.5°C) and leucocytosis (i.e. \>\=10 \*10^9/L) without clinical
  • or radiological evidence of acute cholecystitis. Patients who underwent ERCP
  • are eligible, providing no papillotomy was performed and there are no signs of
  • cholangitis.

Outcomes

Primary Outcomes

Not specified

Similar Trials